HomeRXRX • NASDAQ
add
Recursion Pharmaceuticals Inc
Previous close
$3.63
Day range
$3.44 - $3.61
Year range
$2.98 - $7.18
Market cap
1.87B USD
Avg Volume
21.83M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 35.54M | 681.74% |
Operating expense | 42.17M | -45.36% |
Net income | -108.12M | 39.56% |
Net profit margin | -304.24 | 92.27% |
Earnings per share | -0.21 | 60.38% |
EBITDA | -97.37M | 43.00% |
Effective tax rate | -0.02% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 743.29M | 25.06% |
Total assets | 1.47B | 1.76% |
Total liabilities | 343.26M | -17.05% |
Total equity | 1.13B | — |
Shares outstanding | 527.40M | — |
Price to book | 1.70 | — |
Return on assets | -20.33% | — |
Return on capital | -24.99% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -108.12M | 39.56% |
Cash from operations | -46.07M | 60.09% |
Cash from investing | -1.24M | -100.45% |
Cash from financing | 132.01M | 1,140.77% |
Net change in cash | 86.78M | -48.10% |
Free cash flow | -55.19M | 25.14% |
About
CEO
Founded
2013
Headquarters
Website
Employees
600
